Gregory Evans to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Gregory Evans has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
0.443
-
Ardoin SP, Schanberg LE, Sandborg CI, Barnhart HX, Evans GW, Yow E, Mieszkalski KL, Ilowite NT, Eberhard A, Imundo LF, Kimura Y, Levy D, von Scheven E, Silverman E, Bowyer SL, Punaro L, Singer NG, Sherry DD, McCurdy DK, Klein-Gitelman M, Wallace C, Silver RM, Wagner-Weiner L, Higgins GC, Brunner HI, Jung L, Soep JB, Reed AM, Thompson SD. Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein. Ann Rheum Dis. 2014 Mar; 73(3):557-66.
Score: 0.085
-
Peters SA, Bots ML, den Ruijter HM, Palmer MK, Grobbee DE, Crouse JR, O'Leary DH, Evans GW, Raichlen JS, Moons KG, Koffijberg H. Multiple imputation of missing repeated outcome measurements did not add to linear mixed-effects models. J Clin Epidemiol. 2012 Jun; 65(6):686-95.
Score: 0.079
-
Peters SA, Dogan S, Meijer R, Palmer MK, Grobbee DE, Crouse JR, O'Leary DH, Evans GW, Raichlen JS, Bots ML. The use of plaque score measurements to assess changes in atherosclerotic plaque burden induced by lipid-lowering therapy over time: the METEOR study. J Atheroscler Thromb. 2011; 18(9):784-95.
Score: 0.075
-
Crouse JR, Bots ML, Evans GW, Palmer MK, O'Leary DH, Grobbee DE, Raichlen JS. Does baseline carotid intima-media thickness modify the effect of rosuvastatin when compared with placebo on carotid intima-media thickness progression? The METEOR study. Eur J Cardiovasc Prev Rehabil. 2010 Apr; 17(2):223-9.
Score: 0.069
-
Crouse JR, Raichlen JS, Riley WA, Evans GW, Palmer MK, O'Leary DH, Grobbee DE, Bots ML. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial. JAMA. 2007 Mar 28; 297(12):1344-53.
Score: 0.056
-
Lind L, Peters SA, den Ruijter HM, Palmer MK, Grobbee DE, Crouse JR, O'Leary DH, Evans GW, Raichlen JS, Bots ML. Effect of rosuvastatin on the echolucency of the common carotid intima-media in low-risk individuals: the METEOR trial. J Am Soc Echocardiogr. 2012 Oct; 25(10):1120-1127.e1.
Score: 0.020
-
Peters SA, Palmer MK, den Ruijter HM, Grobbee DE, Crouse JR, O'Leary DH, Evans GW, Raichlen JS, Bots ML. Sample size requirements in trials using repeated measurements and the impact of trial design. Curr Med Res Opin. 2012 May; 28(5):681-8.
Score: 0.020
-
Dogan S, Plantinga Y, Crouse JR, Evans GW, Raichlen JS, O'Leary DH, Palmer MK, Grobbee DE, Bots ML. Algorithms to measure carotid intima-media thickness in trials: a comparison of reproducibility, rate of progression and treatment effect. J Hypertens. 2011 Nov; 29(11):2181-93.
Score: 0.019
-
Peters SA, den Ruijter HM, Palmer MK, Grobbee DE, Crouse JR, O'Leary DH, Evans GW, Raichlen JS, Bots ML. Extensive or restricted ultrasound protocols to measure carotid intima-media thickness: analysis of completeness rates and impact on observed rates of change over time. J Am Soc Echocardiogr. 2012 Jan; 25(1):91-100.
Score: 0.019